Clinical Trial: A Study to Evaluate INCA033989 Administered in Participants With Myeloproliferative Neoplasms
Study Status: Completed
Recruit Status: RECRUITING
Condition: Myeloproliferative Neoplasms
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label, Multicenter Study of INCA033989 in Participants With Myeloproliferative Neoplasms
Brief Summary:
This study is being conducted to evaluate the safety, tolerability, dose-limiting toxicity (DLT) and determine the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDE) of INCA033989 administered in participants with myeloproliferative neoplasms.
Read more